|
Market Closed -
OTC Markets
01:26:36 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0320 USD | -3.90% |
|
+6.67% | +23.08% |
| 19/05 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 17/11 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Biopharmaceuticals | -3.90% | +6.67% | +23.08% | -83.61% | -99.40% | 84.82L |
-
|
-
|
-
|
- Stock Market
- Stocks
- ADAPY Stock
- Charts Adaptimmune Therapeutics plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
